NCT02672527 Trial Comparing Trabectedin to the Best Supportive Care in Patients With Sarcoma Status COMPLETED Phase PHASE3
NCT02666209 Early Patient Access Single Named Patient Program for the Use of Ulocuplumab for the Treatment of Multiple Myeloma Status NO_LONGER_AVAILABLE Phase N/A
NCT02665533 Evaluation of Two Pharmacological Protocols for Pre-emptive Analgesia in Impacted Third Molar Surgery Status COMPLETED Phase NA
NCT02659293 Trial of Carfilzomib, Lenalidomide, Dexamethasone Versus Lenalidomide Alone After Stem-cell Transplant for Multiple Myeloma Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT02655523 A Comparison of Dexamethasone and Triamcinolone for Ultrasound-guided Occipital C2 Nerve Blocks Status WITHDRAWN Phase PHASE4
NCT02654132 An Investigational Immuno-therapy Trial of Pomalidomide and Low-dose Dexamethasone With or Without Elotuzumab to Treat Refractory and Relapsed and Refractory Multiple Myeloma (ELOQUENT-3) Status COMPLETED Phase PHASE2
NCT02653144 the Analgesic Duration of Dexmedetomidine Compared to Dexamethasone as Adjuncts to Single Shot Interscalene Block Status COMPLETED Phase PHASE4
NCT02649790 Study of the Safety, Tolerability and Efficacy of KPT-8602 in Participants With Relapsed/Refractory Cancer Indications Status COMPLETED Phase PHASE1/PHASE2
NCT02649504 Rituximab and Dexamethasone Followed by Mycophenolate Mofetil or Placebo in Patients With Immune Thrombocytopenia Status WITHDRAWN Phase PHASE3
NCT02648490 An Open-label, Phase 1 Study to Determine the Maximum Tolerated Dose of HLX07,in Patients With Advanced Solid Cancers Status COMPLETED Phase PHASE1
NCT02644720 Neural Compensation, Visual Function and Visual Quality After Monofocal or Multifocal Intraocular Lens Implantation Status UNKNOWN Phase NA
NCT02633059 Idasanutlin, Ixazomib Citrate, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma Status COMPLETED Phase PHASE1/PHASE2
NCT02631239 MESA Versus ESA in the Treatment of Early Stage NK/T-cell Lymphoma Status UNKNOWN Phase PHASE3
NCT02628704 Selinexor, Carfilzomib, and Dexamethasone Versus Placebo, Carfilzomib, and Dexamethasone in Multiple Myeloma Status WITHDRAWN Phase PHASE2
NCT02626481 Study of Daratumumab in Combination With Dexamethasone in Resistant or Refractory Multiple Myeloma Status COMPLETED Phase PHASE2
NCT02625181 Real-time Decision Support for Postoperative Nausea and Vomiting (PONV) Prophylaxis Status COMPLETED Phase NA
NCT02619019 Effect of Spinal Dexamethasone During Transuretheral Prostatectomy Status COMPLETED Phase PHASE2